Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practice.
about
Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malariaPharmacotherapy of pediatric metabolic syndromePrimary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.Statin use in Australian children: a retrospective audit of four pediatric hospitals.A randomized, double blind, placebo-controlled pilot trial of the safety and efficacy of atorvastatin in children with elevated low-density lipoprotein cholesterol (LDL-C) and type 1 diabetes.
P2860
Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hyperlipidaemia in paediatric ...... therapy in clinical practice.
@en
Hyperlipidaemia in paediatric ...... therapy in clinical practice.
@nl
type
label
Hyperlipidaemia in paediatric ...... therapy in clinical practice.
@en
Hyperlipidaemia in paediatric ...... therapy in clinical practice.
@nl
prefLabel
Hyperlipidaemia in paediatric ...... therapy in clinical practice.
@en
Hyperlipidaemia in paediatric ...... therapy in clinical practice.
@nl
P2860
P1433
P1476
Hyperlipidaemia in paediatric ...... therapy in clinical practice.
@en
P2093
Adie Viljoen
P2860
P304
P356
10.2165/11319490-000000000-00000
P577
2010-02-01T00:00:00Z
P6179
1040813272